News
Important Only
Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
May 14 (Reuters) - Sernova Biotherapeutics Inc SVA.TO:SERNOVA BIOTHERAPEUTICS PROVIDES POSITIVE INTERIM DATA FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF CELL POUCH BIO-HYBRID ORGAN IN PATIENTS LIVING WITH TYPE 1 DIABETESSERNOVA BIOTHERAPEUTICS INC - CLINICAL STUDY ON TRACK TO MEET ITS PRIMARY AND SECON...Reuters
Wed, May 14
Hungary ruling party drafts bill to crack down on foreign-funded organisations
Hungary bids to crack down on foreign-funded organisationsTargets legal entities whose activities are considered a threatBill condemned by opposition politicians BUDAPEST, May 14 (Reuters) - Hungarian Prime Minister Viktor Orban's Fidesz party submitted a bill to parliament which would list o...Reuters
Wed, May 14
Compre completes liability portfolio transfer from Ethias
By Navneeta NandanMay 14 - (The Insurer) - Legacy specialist Compre announced on Wednesday that it has completed the insurance business transfer of a portfolio of European casualty and motor liabilities from Belgium-based insurer Ethias SA.The portfolio has been assumed by Bermuda-domiciled Compre’s...Reuters
Wed, May 14
Germany's Merz: want to avoid protracted trade conflict with United States
BERLIN, May 14 (Reuters) - Germany wants to avoid a protracted trade conflict with the United States while also supporting the European Union to sign as many trade deals as possible, new Chancellor Friedrich Merz told parliament on Wednesday.Reuters
Wed, May 14
Leaders of Israel's Druze say the state owes it to them to defend Syrian kin
Druze minority straddles Lebanon, Syria and IsraelOver 100 Druze killed in clashes with Islamists in SyriaIsraeli Druze demand IDF protect their Syrian brothersIsrael sees Druze as allies in staving off IslamistsBy Estelle Shirbon HURFEISH, Israel, May 14 (Reuters) - Pained and angered by deadly ...Reuters
Wed, May 14
KP Tissue Releases First Quarter 2025 Financial Results
May 14 (Reuters) - KP Tissue Inc KPT.TO:KP TISSUE RELEASES FIRST QUARTER 2025 FINANCIAL RESULTSKP TISSUE INC: TARIFF IMPACT TO OUR BUSINESS IN Q1 WAS NOT SIGNIFICANTKP TISSUE: ASSUMING A SIMILAR TARIFF ENVIRONMENT, EXPECT Q2 2025 ADJUSTED EBITDA IN RANGE OF $70 MILLION TO $75 MILLIONReuters
Wed, May 14
Well Health Q1 Revenue CAD 294.14 Mln
May 14 (Reuters) - WELL Health Technologies Corp WELL.TO:WELL HEALTH Q1 REVENUE CAD 294.137 MILLION VERSUS. IBES ESTIMATE CAD 283.9 MILLIONWELL HEALTH Q1 ADJUSTED EBITDA CAD 27.577 MILLIONWELL HEALTH Q1 ADJUSTED GROSS MARGIN 39.9%WELL HEALTH Q1 ADJUSTED EPS CAD 0.03WELL HEALTH Q1 NET INCOME CAD -41....Reuters
Wed, May 14
Editas Medicine Reports New In Vivo Data Highlighting The Potential Of Editas’ Gene Upregulation Strategy In Hscs At The American Society Of Gene And Cell Therapy Annual Meeting
May 14 (Reuters) - Editas Medicine Inc EDIT.O:EDITAS MEDICINE REPORTS NEW IN VIVO DATA HIGHLIGHTING THE POTENTIAL OF EDITAS’ GENE UPREGULATION STRATEGY IN HSCS AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETINGReuters
Wed, May 14
Pasithea Therapeutics Announces Initiation Of Phase 1/1B Study Of Pas-004 In Adult Nf1 Patients And Activation Of First Clinical Trial Site
May 14 (Reuters) - Pasithea Therapeutics Corp KTTA.O:PASITHEA THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1/1B STUDY OF PAS-004 IN ADULT NF1 PATIENTS AND ACTIVATION OF FIRST CLINICAL TRIAL SITEReuters
Wed, May 14
Ascot to raise $350 million to bolster balance sheet and fuel long-term growth
By Ryan HewlettMay 14 - (The Insurer) - Ascot is to raise $350 million through an offering of senior notes, which the Bermuda-based carrier said would further strengthen its balance sheet and help to fuel long-term profitable growth.The (re)insurer said in a statement on Tuesday that it has priced i...Reuters
Wed, May 14
